Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 837 (ZNF837) is a human protein encoded by the ZNF837 gene located on chromosome 19q13.43 with a C2H2-type zinc finger motif, functioning primarily as a DNA-binding transcription factor. ZNF837 is predicted to participate in the regulation of gene expression by RNA polymerase II and is predominantly localized in the nucleus. It exhibits identical protein binding activity, interacts with metal ions (zinc), and is involved in the regulation of transcription, consistent with the general properties of the zinc finger protein family. ZNF837 has low expression levels in tissues such as pancreas, liver, uterus, and muscle, with evidence suggesting altered expression in disease states, though its precise disease associations and molecular functions remain to be clarified. There are no current reports of ZNF837 being directly targeted by therapeutic drugs, used as a biomarker, or implicated in safety concerns[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 837 (ZNF837).